superRCA® MRD Assays
superRCA® technology is an advanced molecular assay for flow cytometry-based mutation detection that enables ultra-sensitive Measurable Residual Disease (MRD) evaluation in hemato-oncology research. By precisely amplifying rare genetic mutations, superRCA® assays enable clinical researchers to gain a deeper understanding of disease progression and molecular relapse. Choose from over 150 made-to-order, pre-verified assays designed for use with the superRCA® Accessory Kit, covering the majority of the mutational landscape of acute myeloid leukemia (AML) MRD research.
- Detects rare mutations with ultra-high sensitivity
- Provides faster results to identify targetable mutations
- Compatible with any standard flow cytometer with a plate loader module
- Enables high-throughput automated processing
Explore superRCA Kits
superRCA® Features
superRCA® technology from our partner Rarity Bioscience is a highly specific molecular assay for ultra-sensitive MRD evaluation, enabling rapid and simultaneous analysis of single or multiple DNA mutations using flow cytometry.
Higher Sensitivity
- Delivers 10 to 100 times greater sensitivity than conventional methods such as NGS, digital PCR, or qPCR - detecting mutations at frequencies as low as 1 in 100,000 cells
- Enables ultra-sensitive MRD evaluation to meet the demands of modern hemato-oncology research
Faster Results
- Achieve rapid turnaround for timely identification of targetable mutations and early relapse detection
- The workflow is automation-ready, enabling high-throughput and standardized processing for consistent, efficient results
Flexible Target Selection
- Offers pre-defined and customizable gene panels to support a wide range of mutation detection applications
- Enables simultaneous detection of single or multiple mutation targets—ideal for multiplex assays in MRD and oncology research workflows
Seamless Integration
- Compatible with any standard flow cytometer equipped with a plate loader
- No need for specialized equipment or extensive training - superRCA® assays fit right into your existing lab infrastructure